How has been the historical performance of Medico Remedies?
Medico Remedies has exhibited consistent growth in net sales and profits, with net sales increasing from 97.69 Cr in Mar'19 to 150.94 Cr in Mar'25, and profit after tax rising from 1.57 Cr to 10.09 Cr in the same period. The company's total assets and liabilities also grew significantly, reflecting a strong financial position.
Answer:The historical performance of Medico Remedies shows a consistent growth trend in net sales and profits over the years.Breakdown:
Medico Remedies has demonstrated a steady increase in net sales, rising from 97.69 Cr in Mar'19 to 150.94 Cr in Mar'25. This growth is accompanied by a corresponding rise in total operating income, which reached 150.94 Cr in Mar'25, up from 144.92 Cr in Mar'24. The company's operating profit (PBDIT) also improved significantly, climbing to 17.69 Cr in Mar'25 from 4.66 Cr in Mar'19. Profit before tax followed a similar upward trajectory, increasing to 13.50 Cr in Mar'25 from 2.18 Cr in Mar'19, while profit after tax reached 10.09 Cr in Mar'25, up from 1.57 Cr in Mar'19. The company's total assets grew from 75.27 Cr in Mar'20 to 119.55 Cr in Mar'25, reflecting a robust expansion in its financial position. Additionally, total liabilities increased from 75.27 Cr in Mar'20 to 119.55 Cr in Mar'25, indicating a rise in financial obligations alongside asset growth. The cash flow from operating activities showed fluctuations, with a notable cash flow of 2.00 Cr in Mar'24, contrasting with previous years. Overall, Medico Remedies has shown a positive trend in revenue and profitability, positioning itself favorably in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
